Technology innovations are amongst the key growth enablers for every industry. Increasing globalization and ever-expanding supplychain networks are parallelly followed by new challenges which require innovative solutions. Investment in research and development activities help industries to stay on the path of continuous improvement, manufacturing market fit products, and ensuring lasting progress.
The COVID-19 pandemic impacted every industry and forced every stakeholder to transform their workflow and radicalize the supply chain. Technology solutions such as the adoption of digital technologies and automation enabled many business models to outpace the pandemic, ensuring sustainable growth.
With rapidly declining costs and financial incentives from government bodies, advanced batteries for automotive, behind-the-meter (BTM), and utility/grid-scale storage of renewable energy are set to accelerate the global energy transition.
BYD, CATL, 24m, VionX Energy, Solid Power, QuantumScape, Redflow, ESS Inc, ProLogium, Primus Power, Invinity, Energy Systems, and Samsung
Vaccine Technology Platforms
Vaccine Formulation
Vaccine Manufacturing
Vaccine Delivery Platforms
Vaccination has been a valuable tool to save millions of lives. However, new vaccine design approaches along with manufacturing, formulation, and delivery systems are transforming vaccines. The next-generation vaccines such as nanoparticles including virus-like particles, mRNA, synthetic & recombinant vaccines offer several advantages. New technologies aim to elicit a strong and long-lasting immune response through both arms of the immune system – cellular and humoral – minimizing side effects and providing protection across all age groups.
Nucleic acid-based vaccines are likely to commercialize in 2021 - Nucleic acid DNA and RNA-based vaccines do not require laborious production of pathogen proteins and, thus, production is much faster. However, the COVID-19 pandemic has given an opportunity to test several vaccine platforms, and DNA and RNA vaccines are leading the race. Frost & Sullivan estimates that by the end of 2021, approximately 4.12 billion COVID-19 vaccine doses will be delivered globally to immunize three priority target groups.
CureVac, Moderna, Pfizer-BioNTech, Johnson & Johnson, CanSinoBIO, The University of Oxford, and AstraZeneca
The healthcare system is shifting from more reactive to proactive care. Early signs of diseases and disease prognosis can help make better-informed intervention decisions and improve health outcomes. Technologies such as digital biomarkers, AI-based diagnostics, intelligent imaging analysis, and genetic testing enable this technology trend. This trend is key in improving population health.
Chronic Diseases: Parameter: Metabolic Conditions, Neurodegenerative diseases, Oncology Companies: CureMetrix, Fitbit by Google
Respiratory Conditions: Parameter: Body temperature and respiration rate Companies: Qure.ai, Biovitals Sentinel by Biofourmis
Drug Development: Parameter: Measurement for precision dosing Companies: Sweatronics Platform By Eccrine Systems, Inc.
Fitbit, Kinsa, Eccrine Systems,Inc., MC10, ResMed, Biofourmis, Ultromics, Ezra, Zebra Medical Vision, Cercare Medical, and Cure Metrix
Transition in energy, mobility, and electronics industries towards sustainable, greener, and miniaturized devices have created the need for intelligent smart materials that can self-adapt, self-heal and be responsive to external and internal stimuli. These materials can be pre-programmed to act on certain triggers and help in increasing the performance, durability, and efficiency of end products and components. They can also be programmed to exhibit desired characteristics that can help in achieving new product formats and functions.
Intelligent materials, also known as 4D Materials or Smart/ Programmable materials, are expected to have a high demand in the energy, internet of things (IoT), aerospace, and automotive industries from 2021 to 2025. Many OEMs are collaborating with material manufacturers to develop products with tunable properties that can meet their specific demands, such as self-healing and scratchproof characteristics.
As R&D focuses on the synthesis of new intelligent materials, the demand for pre-programmable flexible materials with inbuilt sensing and actuating abilities that allow self-transformation and offer excellent biocompatibility are likely to increase in the soft robotics, tissue engineering, and flexible electronics fields in the near term.
The future of intelligent materials is very promising, and they are likely to have huge investment opportunities in the development of hydrophobic protective coatings and multifunctional sealants with properties like self-healing, self-cleaning, water-repelling, high temperature, scratch-proofing, resisting corrosion, and gas barrier properties. Their demand is likely to increase in O&G, infrastructure, transportation, and general industrial applications due to their ability to extend a structure's service life in response to external stimuli.
Frost & Sullivan has spent the last 60 years learning how to navigate disruption and transformation to create growth opportunities that allow businesses to thrive. We’ve come to believe that the growth of companies cannot be separated from the stakeholders around us and that when properly managed, company growth not only impacts the bottom line but addresses many global challenges that face society as a whole, including economic inequality, climate change, and social inclusion. We intend to spend the next 60 years enabling growth opportunities that don’t just make good business sense – they become a moral imperative.
SAN ANTONIO 7550 1hH W Dr. #400, Suite 400, San Antonio, TX 78229, United States Tel. +1,877,463,7678
LONDON Ground floor – Building 11 Chiswick Business Park 566 Chiswick High Road London W4 5YS Tel: +44 (0)20 8996 8500
TOKYO Akasaka Park Building 5-2-20 Akasaka,.Minato-Ku Tokyo 107-6123 Japan Tel: +81.0.3.4550.2210
BUENOS AIRES 1061 Luis Maria Campos Ave. 9th Floor, Buenos Aires C1426BOI, Argentina